These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24894105)

  • 1. Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.
    Alarfaj AS; Khalil N
    Clin Rheumatol; 2014 Dec; 33(12):1731-6. PubMed ID: 24894105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease.
    Harward LE; Mitchell K; Pieper C; Copland S; Criscione-Schreiber LG; Clowse ME
    Lupus; 2013 Jan; 22(1):81-6. PubMed ID: 23263867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian function is preserved in women with severe systemic lupus erythematosus after a 6-month course of cyclophosphamide followed by mycophenolate mofetil.
    Laskari K; Zintzaras E; Tzioufas AG
    Clin Exp Rheumatol; 2010; 28(1):83-6. PubMed ID: 20346244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
    Huong DL; Amoura Z; Duhaut P; Sbai A; Costedoat N; Wechsler B; Piette JC
    J Rheumatol; 2002 Dec; 29(12):2571-6. PubMed ID: 12465154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.
    Katsifis GE; Tzioufas AG
    Lupus; 2004; 13(9):673-8. PubMed ID: 15485101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.
    Mok CC; Lau CS; Wong RW
    Arthritis Rheum; 1998 May; 41(5):831-7. PubMed ID: 9588734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy.
    Sen M; Kurl A; Khosroshahi A
    Lupus; 2021 Aug; 30(9):1509-1514. PubMed ID: 34053364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone.
    Tamirou F; Husson SN; Gruson D; Debiève F; Lauwerys BR; Houssiau FA
    Arthritis Rheumatol; 2017 Jun; 69(6):1267-1271. PubMed ID: 28235250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide induced amenorrhoea in pre-menopausal women with systemic lupus erythematosus].
    Cunha I; Saavedra MJ; Pereira da Silva JA; Malcata A
    Acta Reumatol Port; 2008; 33(1):69-76. PubMed ID: 18344924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A multicenter study on the tolerance of intravenous low-dose cyclophosphamide in systemic lupus erythematosus].
    Shao M; Guo HF; Lei LY; Zhao Q; Ding YJ; Lin J; Wu R; Yu F; Li YC; Miao HL; Zhang LY; DU Y; Jiao RY; Pang LX; Long L; Li ZG; Li R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1112-1116. PubMed ID: 36533341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
    Somers EC; Marder W; Christman GM; Ognenovski V; McCune WJ
    Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: a case-control study.
    Baba S; Katsumata Y; Kawaguchi Y; Gono T; Sugiura T; Kanno T; Hara M; Yamanaka H
    BMC Womens Health; 2011 Jun; 11():28. PubMed ID: 21663683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
    Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
    Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy.
    Park MC; Park YB; Jung SY; Chung IH; Choi KH; Lee SK
    Lupus; 2004; 13(8):569-74. PubMed ID: 15462485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Al Arfaj AS; Khalil N
    Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The risk of sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy].
    Liu G; Chen Y; Wang L; Zuo C; Xie Q; Wang Z; Lin M
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):294-5, 306. PubMed ID: 12600113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    Garnier C; Ribes D; Chauveau D; Huart A; Pugnet G; Adoue D; Prevot G; Alric L; Delobel P; Derumeaux H; Mengelle C; Sailler L; Moulis G
    J Rheumatol; 2018 Nov; 45(11):1541-1548. PubMed ID: 30008461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus.
    Wang CL; Wang F; Bosco JJ
    Lupus; 1995 Feb; 4(1):11-4. PubMed ID: 7767332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.